West Pharmaceutical Services Operating Margin 2010-2024 | WST

Current and historical operating margin for West Pharmaceutical Services (WST) over the last 10 years. The current operating profit margin for West Pharmaceutical Services as of March 31, 2024 is 19.62%.
West Pharmaceutical Services Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-03-31 $2.93B $0.64B 21.99%
2023-12-31 $2.95B $0.68B 22.92%
2023-09-30 $2.93B $0.65B 22.04%
2023-06-30 $2.87B $0.65B 22.81%
2023-03-31 $2.88B $0.70B 24.24%
2022-12-31 $2.89B $0.73B 25.42%
2022-09-30 $2.91B $0.79B 27.09%
2022-06-30 $2.93B $0.78B 26.73%
2022-03-31 $2.88B $0.77B 26.58%
2021-12-31 $2.83B $0.75B 26.54%
2021-09-30 $2.68B $0.68B 25.50%
2021-06-30 $2.52B $0.60B 23.86%
2021-03-31 $2.33B $0.50B 21.28%
2020-12-31 $2.15B $0.41B 18.96%
2020-09-30 $2.04B $0.37B 18.11%
2020-06-30 $1.95B $0.34B 17.32%
2020-03-31 $1.89B $0.31B 16.62%
2019-12-31 $1.84B $0.30B 16.13%
2019-09-30 $1.79B $0.29B 15.90%
2019-06-30 $1.77B $0.28B 15.78%
2019-03-31 $1.75B $0.26B 14.78%
2018-12-31 $1.72B $0.24B 13.97%
2018-09-30 $1.71B $0.23B 13.67%
2018-06-30 $1.68B $0.24B 14.06%
2018-03-31 $1.63B $0.22B 13.39%
2017-12-31 $1.60B $0.23B 14.13%
2017-09-30 $1.57B $0.22B 13.98%
2017-06-30 $1.55B $0.21B 13.40%
2017-03-31 $1.54B $0.23B 14.72%
2016-12-31 $1.51B $0.20B 12.92%
2016-09-30 $1.49B $0.19B 12.58%
2016-06-30 $1.46B $0.13B 9.07%
2016-03-31 $1.43B $0.11B 7.71%
2015-12-31 $1.40B $0.13B 9.14%
2015-09-30 $1.39B $0.13B 9.20%
2015-06-30 $1.40B $0.18B 12.55%
2015-03-31 $1.41B $0.19B 13.54%
2014-12-31 $1.42B $0.18B 12.80%
2014-09-30 $1.42B $0.17B 12.30%
2014-06-30 $1.40B $0.17B 12.13%
2014-03-31 $1.38B $0.16B 11.55%
2013-12-31 $1.37B $0.16B 11.91%
2013-09-30 $1.35B $0.16B 11.72%
2013-06-30 $1.31B $0.14B 10.99%
2013-03-31 $1.29B $0.14B 10.62%
2012-12-31 $1.27B $0.14B 10.73%
2012-09-30 $1.24B $0.13B 10.56%
2012-06-30 $1.23B $0.13B 10.65%
2012-03-31 $1.21B $0.12B 10.14%
2011-12-31 $1.19B $0.11B 9.23%
2011-09-30 $1.17B $0.09B 7.58%
2011-06-30 $1.15B $0.09B 7.65%
2011-03-31 $1.13B $0.09B 8.09%
2010-12-31 $1.11B $0.09B 8.24%
2010-09-30 $1.12B $0.11B 9.55%
2010-06-30 $1.11B $0.11B 9.74%
2010-03-31 $1.09B $0.11B 9.74%
2009-12-31 $1.06B $0.10B 9.29%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $24.159B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Cooper (COO) United States $18.860B 28.54
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00